Early Cellular Responses of Prostate Carcinoma Cells to Sepantronium Bromide (YM155) Involve Suppression of mTORC1 by AMPK

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-47573-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Anti-Gd2 Immunoliposomes for Targeted Delivery of the Survivin Inhibitor Sepantronium Bromide (YM155) to Neuroblastoma Tumor Cells

Pharmaceutical Research
Organic ChemistryBiotechnologyMolecular MedicinePharmacologyPharmaceutical Science
2018English

YM155 Induces EGFR Suppression in Pancreatic Cancer Cells

PLoS ONE
Multidisciplinary
2012English

Reactive Nitrogen Species Regulate Autophagy Through ATM-AMPK-TSC2-mediated Suppression of mTORC1

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2013English

AMP-activated Protein Kinase (AMPK) Control of mTORC1 Is P53- And TSC2-independent in Pemetrexed-Treated Carcinoma Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2015English

Suppression of Dendritic Cells by IL10 Limits Chemotherapy Responses

Cancer Discovery
Oncology
2014English

Detection of Cellular Responses to Toxicants by Dielectrophoresis

Biochimica et Biophysica Acta - Biomembranes
BiochemistryCell BiologyBiophysics
2002English

Lysis of Prostate Carcinoma Cells by Trifunctional Bispecific Antibodies (αEpCAM × αCD3)

Journal of Histochemistry and Cytochemistry
AnatomyHistology
2001English

Education Concerning Carcinoma of Prostate and Its Early Detection

Central European Journal of Urology
Urology
2011English

Suppression of Macrophage Inflammatory Responses by PPARs

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy